Literature DB >> 17210135

Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.

Zubin Bhagwagar1, Marzena Wylezinska, Peter Jezzard, John Evans, Fiona Ashworth, Akeem Sule, Paul M Matthews, Philip J Cowen.   

Abstract

BACKGROUND: Studies using proton magnetic resonance spectroscopy (MRS) have indicated that unmedicated, acutely depressed patients have decreased levels of gamma-aminobutyric acid (GABA) in occipital cortex. Cortical levels of glutamate (Glu) may be increased, although these data are less consistent. The aim of this study was to use MRS to determine whether changes in GABA and Glu levels were present in patients with mood disorders who had recovered and were no longer taking medication.
METHODS: An [1H]-MRS was used to measure levels of GABA, of the combined concentration of Glu and glutamine (Gln), and of N-acetylaspartate (NAA) in occipital cortex in medication-free, fully recovered subjects with a history of recurrent unipolar depression (n = 15), bipolar disorder (n = 16), and a group of healthy controls (n = 18).
RESULTS: Occipital levels of GABA and NAA were significantly lower in recovered depressed and bipolar subjects than in healthy controls, whereas Glu +Gln concentrations were higher.
CONCLUSIONS: Our data suggest that recovered unmedicated subjects with a history of mood disorder have changes in cortical concentrations of GABA, NAA, and Glu +Gln. These biochemical abnormalities may be markers of a trait vulnerability to mood disorder, rather than neurochemical correlates of an abnormal mood state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210135     DOI: 10.1016/j.biopsych.2006.08.048

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  97 in total

Review 1.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

Review 2.  Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

Authors:  Cagri Yüksel; Dost Öngür
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

3.  Depressive-like behavior in adolescents after maternal separation: sex differences, controllability, and GABA.

Authors:  Melanie P Leussis; Nadja Freund; Heather C Brenhouse; Britta S Thompson; Susan L Andersen
Journal:  Dev Neurosci       Date:  2012-07-06       Impact factor: 2.984

4.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

Review 5.  Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.

Authors:  Jun Chen; Yiru Fang; David E Kemp; Joseph R Calabrese; Keming Gao
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

6.  Targeting glial physiology and glutamate cycling in the treatment of depression.

Authors:  Gerald W Valentine; Gerard Sanacora
Journal:  Biochem Pharmacol       Date:  2009-04-17       Impact factor: 5.858

7.  Increased use-dependent plasticity in chronic insomnia.

Authors:  Rachel E Salas; Joseph M Galea; Alyssa A Gamaldo; Charlene E Gamaldo; Richard P Allen; Michael T Smith; Gabriela Cantarero; Barbara D Lam; Pablo A Celnik
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

8.  Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.

Authors:  Dorota Maciag; Jonathan Hughes; Gillian O'Dwyer; Yilianys Pride; Craig A Stockmeier; Gerard Sanacora; Grazyna Rajkowska
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

9.  Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Authors:  Brian P Brennan; James I Hudson; J Eric Jensen; Julie McCarthy; Jacqueline L Roberts; Andrew P Prescot; Bruce M Cohen; Harrison G Pope; Perry F Renshaw; Dost Ongür
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

10.  Enhanced visual motion perception in major depressive disorder.

Authors:  Julie D Golomb; Jenika R B McDavitt; Barbara M Ruf; Jason I Chen; Aybala Saricicek; Kathleen H Maloney; Jian Hu; Marvin M Chun; Zubin Bhagwagar
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.